{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:56:41Z","timestamp":1770069401870,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s40261-013-0101-1","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T07:03:53Z","timestamp":1373353433000},"page":"579-587","source":"Crossref","is-referenced-by-count":43,"title":["Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Pyry Antti","family":"V\u00e4litalo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuula","family":"Ahtola-S\u00e4til\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wighton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Sarapohja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasi","family":"Pohjanjousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Garratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"101_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(88)90744-3","volume":"150","author":"R Virtanen","year":"1988","unstructured":"Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9\u201314.","journal-title":"Eur J Pharmacol."},{"key":"101_CR2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00000542-200411000-00005","volume":"101","author":"YW Hsu","year":"2004","unstructured":"Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004;101:1066\u201376.","journal-title":"Anesthesiology."},{"key":"101_CR3","doi-asserted-by":"crossref","first-page":"P355","DOI":"10.1186\/cc9775","volume":"15","author":"MM Mirski","year":"2011","unstructured":"Mirski MM, Gill RG, Murakami PM, Thompson CT, Lewin JL. Dexmedetomidine improves attention and recall in agitated critically ill patients. Crit Care. 2011;15:P355.","journal-title":"Crit Care."},{"key":"101_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00134-002-1579-9","volume":"29","author":"M Venn","year":"2003","unstructured":"Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med. 2003;29:201\u20137.","journal-title":"Intensive Care Med."},{"key":"101_CR5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2012.304","volume":"307","author":"SM Jakob","year":"2012","unstructured":"Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307:1151\u201360.","journal-title":"JAMA."},{"key":"101_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<519::AID-JPS9>3.0.CO;2-U","volume":"89","author":"S Dutta","year":"2000","unstructured":"Dutta S, Lal R, Karol MD, Cohen T, Ebert T. Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci. 2000;89:519\u201327.","journal-title":"J Pharm Sci."},{"key":"101_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00000542-199305000-00002","volume":"78","author":"JB Dyck","year":"1993","unstructured":"Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993;78:813\u201320.","journal-title":"Anesthesiology."},{"key":"101_CR8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2125.2003.01944.x","volume":"56","author":"M Anttila","year":"2003","unstructured":"Anttila M, Penttila J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol. 2003;56:691\u20133.","journal-title":"Br J Clin Pharmacol."},{"key":"101_CR9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1213\/00000539-199711000-00033","volume":"85","author":"P Talke","year":"1997","unstructured":"Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg. 1997;85:1136\u201342.","journal-title":"Anesth Analg."},{"key":"101_CR10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00000539-200111000-00031","volume":"93","author":"AM Wolf De","year":"2001","unstructured":"De Wolf AM, Fragen RJ, Avram MJ, Fitzgerald PC, Rahimi-Danesh F. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg. 2001;93:1205\u20139.","journal-title":"Anesth Analg."},{"key":"101_CR11","doi-asserted-by":"crossref","first-page":"R257","DOI":"10.1186\/cc10518","volume":"15","author":"T Iirola","year":"2011","unstructured":"Iirola T, Aantaa R, Laitio R, Kentala E, Lahtinen M, Wighton A, et al. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care. 2011;15:R257.","journal-title":"Crit Care."},{"key":"101_CR12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/bja\/aer441","volume":"108","author":"T Iirola","year":"2012","unstructured":"Iirola T, Ihmsen H, Laitio R, Kentala E, Aantaa R, Kurvinen J-P, et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth. 2012;108:460\u20138.","journal-title":"Br J Anaesth."},{"key":"101_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1399-6576.2010.02392.x","volume":"55","author":"L Lin","year":"2011","unstructured":"Lin L, Guo X, Zhang MZ, Qu CJ, Sun Y, Bai J. Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients. Acta Anaesthesiol Scand. 2011;55:359\u201367.","journal-title":"Acta Anaesthesiol Scand."},{"key":"101_CR14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/bja\/88.5.669","volume":"88","author":"RM Venn","year":"2002","unstructured":"Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth. 2002;88:669\u201375.","journal-title":"Br J Anaesth."},{"key":"101_CR15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1124\/dmd.108.021709","volume":"36","author":"S Kaivosaari","year":"2008","unstructured":"Kaivosaari S, Toivonen P, Aitio O, Sipila J, Koskinen M, Salonen JS, et al. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos. 2008;36:1529\u201337.","journal-title":"Drug Metab Dispos."},{"key":"101_CR16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00134-008-1296-0","volume":"35","author":"E Ruokonen","year":"2009","unstructured":"Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST, et al. Dexmedetomidine versus propofol\/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2009;35:282\u201390.","journal-title":"Intensive Care Med."},{"key":"101_CR17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/rcm.1548","volume":"18","author":"QC Ji","year":"2004","unstructured":"Ji QC, Zhou JY, Gonzales RJ, Gage EM, El-Shourbagy TA. Simultaneous quantitation of dexmedetomidine and glucuronide metabolites (G-Dex-1 and G-Dex-2) in human plasma utilizing liquid chromatography with tandem mass spectrometric detection. Rapid Commun Mass Spectrom. 2004;18:1753\u201360.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"101_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31\u201341.","journal-title":"Nephron."},{"key":"101_CR19","unstructured":"Beal SL, Sheiner LB, Boeckmann A, Bauer RJ. NONMEM user\u2019s guides. Ellicott City: ICON Development Solutions; 2009."},{"key":"101_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson EN, Jonsson N. PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79:241\u201357.","journal-title":"Comput Methods Programs Biomed."},{"key":"101_CR21","unstructured":"Karlsson MO. A full model approach based on the covariance matrix of parameters and covariates. PAGE. 2012;Abstr 2455. http:\/\/www.page-meeting.org\/?abstract=2455 . Accessed 20 Jun 2013"},{"key":"101_CR22","volume-title":"Clinical pharmacokinetics and pharmacodynamics: concepts and applications","author":"M Rowland","year":"2011","unstructured":"Rowland M, Tozer TN. Clinical pharmacokinetics and pharmacodynamics: concepts and applications. Philadelphia: Wolters Kluwer Health\/Lippincott William & Wilkins; 2011."},{"key":"101_CR23","doi-asserted-by":"crossref","unstructured":"Dodek P, Kozak JF, Norena M, Wong H. More men than women are admitted to 9 intensive care units in British Columbia. J Crit Care. 2009;24:630.e1\u20138.","DOI":"10.1016\/j.jcrc.2009.02.010"},{"key":"101_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"SL Beal","year":"2001","unstructured":"Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn. 2001;28:481\u2013504.","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"101_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/bean.2000.0081","volume":"14","author":"MD Karol","year":"2000","unstructured":"Karol MD, Maze M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Best Pract Res Clin Anaesthesiol. 2000;14:261\u20139.","journal-title":"Best Pract Res Clin Anaesthesiol."},{"key":"101_CR26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10928-011-9211-7","volume":"38","author":"L Choi","year":"2011","unstructured":"Choi L, Caffo BS, Kohli U, Pandharipande P, Kurnik D, Ely EW, et al. A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic study. J Pharmacokinet Pharmacodyn. 2011;38:613\u201336.","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"101_CR27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00228-011-1208-z","volume":"68","author":"U Kohli","year":"2012","unstructured":"Kohli U, Pandharipande P, Muszkat M, Sofowora GG, Friedman EA, Scheinin M, et al. CYP2A6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol. 2012;68:937\u201342.","journal-title":"Eur J Clin Pharmacol."},{"key":"101_CR28","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/00005373-198309000-00009","volume":"23","author":"ME Gottlieb","year":"1983","unstructured":"Gottlieb ME, Sarfeh IJ, Stratton H, Goldman ML, Newell JC, Shah DM. Hepatic perfusion and splanchnic oxygen consumption in patients postinjury. J Trauma. 1983;23:836\u201343.","journal-title":"J Trauma."},{"key":"101_CR29","first-page":"707","volume":"44","author":"Z Abdel-Razzak","year":"1993","unstructured":"Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol. 1993;44:707\u201315.","journal-title":"Mol Pharmacol."},{"key":"101_CR30","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00003088-200241140-00002","volume":"41","author":"P Paepe De","year":"2002","unstructured":"De Paepe P, Belpaire FM, Buylaert WA. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. Clin Pharmacokinet. 2002;41:1135\u201351.","journal-title":"Clin Pharmacokinet."},{"key":"101_CR31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1472-8206.2008.00623.x","volume":"22","author":"G Zagli","year":"2008","unstructured":"Zagli G, Tarantini F, Bonizzoli M, Di Filippo A, Peris A, De Gaudio AR, et al. Altered pharmacology in the intensive care unit patient. Fundam Clin Pharmacol. 2008;22:493\u2013501.","journal-title":"Fundam Clin Pharmacol."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-013-0101-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0101-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T18:06:52Z","timestamp":1563386812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-013-0101-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s40261-013-0101-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}